• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Detection for predictive factors of estrogen addition and depletion therapy in endocrine therapy-resistant breast cancer

Research Project

Project/Area Number 26461952
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General surgery
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

Omoto Yoko  京都府立医科大学, 医学(系)研究科(研究院), 客員講師 (80642561)

Co-Investigator(Kenkyū-buntansha) 岩瀬 弘敬  熊本大学, 大学院生命科学研究部(医), 教授 (40211065)
山本 豊  熊本大学, 大学院生命科学研究部(医), 准教授 (20398217)
田口 哲也  京都府立医科大学, 医学(系)研究科(研究院), 教授 (80243260)
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsエストロゲンレセプター / 乳癌 / 内分泌療法 / ホルモン療法 / ホルモン依存性 / 内分泌療法耐性乳癌 / エストロゲン療法
Outline of Final Research Achievements

The purpose of this study is to detect predictive factors of endocrine therapy sensitivity of breast cancer. A specimen from estrogen receptor (ER) -positive recurrent breast cancer patient who became aromatase inhibitor (AI) resistant during long-term AI treatment was applied for this study. It was suggested that the non-genomic pathway was involved in the difference in response of AI treatment. Furthermore, we succeeded in pointing out that early ER genetic change is involved in a change in susceptibility to hormonal therapy and we also demonstrated that the blood sample is also possible to use for monitoring of this early gene mutation. Our finding has a possibility to provide a great benefit to breast cancer patients to predict endocrine therapy responsiveness.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report

Research Products

(10 results)

All 2016 2015 2014

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Open Access: 4 results,  Acknowledgement Compliant: 4 results) Presentation (6 results) (of which Int'l Joint Research: 5 results)

  • [Journal Article] Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.2016

    • Author(s)
      63.Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Omoto Y, Iwase H.
    • Journal Title

      Oncotarget

      Volume: 7 Pages: 32504-18

    • DOI

      10.18632/oncotarget.8839

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens.2015

    • Author(s)
      Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Omoto Y, Iwase H.
    • Journal Title

      Transl Res.

      Volume: 166 Pages: 540-553

    • DOI

      10.1016/j.trsl.2015.09.003

    • Related Report
      2015 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.2015

    • Author(s)
      Omoto Y, Iwase H.
    • Journal Title

      Cancer Sci

      Volume: 106 Pages: 337-343

    • DOI

      10.1111/cas.12613

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.2015

    • Author(s)
      Omoto Y, Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Hayashi M, Sueta A, Fujiwara S, Taguchi T, Iwase H.
    • Journal Title

      Springerplus.

      Volume: 108 Pages: 1-9

    • DOI

      10.1186/s40064-015-0851-8

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Presentation] Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients.2016

    • Author(s)
      Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Sueta A, Tomiguchi M and Iwase H.
    • Organizer
      The 39th San Antonio Breast Cancer Symposium
    • Place of Presentation
      San Antonio, TX, USA
    • Year and Date
      2016-12-07
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Clinical significance of sequential measurement of ESR1 mutations in plasma cell-free DNA in metastatic breast cancer.2016

    • Author(s)
      Hirotaka Iwase.
    • Organizer
      7th Seoul Breast Cancer Symposium
    • Place of Presentation
      Seoul, South Korea
    • Year and Date
      2016-09-03
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples.2015

    • Author(s)
      Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Iwase H
    • Organizer
      The 38th San Antonio Breast Cancer Symposium
    • Place of Presentation
      San Antonio, TX
    • Year and Date
      2015-12-12
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] ESR1 gene alterations in the metastatic breast cancer with resistance to aromatase inhibitor.2015

    • Author(s)
      Iwase H, Takeshita T, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Yamamoto Y
    • Organizer
      Advances in Breast Cancer Research
    • Place of Presentation
      Bellevue, Washington
    • Year and Date
      2015-10-10
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] Clinical significance of ESR1 mutations by cell-free DNA in recurrent/metastatic breast cancer.2015

    • Author(s)
      Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Inao T, Sueta A, Fujiwara S, Iwase H
    • Organizer
      Advances in Breast Cancer Research
    • Place of Presentation
      Bellevue, Washington
    • Year and Date
      2015-10-10
    • Related Report
      2015 Research-status Report
    • Int'l Joint Research
  • [Presentation] 長期にアロマターゼ阻害薬を投与したER陽性再発乳癌患者におけるEE2 治療前後の遺伝子発現の免染での検討2014

    • Author(s)
      大本陽子、竹下卓志、指宿睦子、藤原沙織、末田愛子、林 光博、山本聡子、稲尾瞳子、奥村恭博、村上敬一、山本 豊、岩瀬弘敬
    • Organizer
      第22回日本乳癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      2014-07-10
    • Related Report
      2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi